Kung Winston bought JANX

June 11, 2026 · Form 4 insider transaction

Kung Winston bought 5,500 shares of Janux Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
5,500
Price
$0.00
Total value
N/A
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 11, 2026
Filing dateJune 12, 2026
Shares owned after11,750
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of (i) June 11, 2027 and (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continuous service on such date.

View the original Form 4 on SEC EDGAR